ICD-10 Coding for Steatohepatitis(E11.9U, E66.9U, K75.81)
Learn about ICD-10 coding for steatohepatitis, including key codes, documentation requirements, and common pitfalls.
Complete code families applicable to Steatohepatitis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| K75.81 | Nonalcoholic steatohepatitis (NASH) | Use when there is documented inflammation and liver injury consistent with NASH. |
|
| K76.0 | Fatty (change of) liver, not elsewhere classified | Use when there is fatty liver without evidence of inflammation. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutSteatohepatitis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Steatohepatitis.
Vague documentation of liver condition
Impact
Clinical: Leads to misdiagnosis and treatment errors., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims due to insufficient documentation.
Mitigation
Use specific terms like 'steatohepatitis with ballooning degeneration'., Ensure biopsy results are detailed.
Confusing NAFLD with NASH
Impact
Reimbursement: Incorrect coding can lead to improper DRG assignment., Compliance: May result in audit issues due to inaccurate coding., Data Quality: Affects clinical data accuracy and patient records.
Mitigation
Ensure documentation specifies presence or absence of inflammation.
Inadequate documentation of fibrosis
Impact
Lack of specific fibrosis staging can lead to audit flags.
Mitigation
Ensure all biopsy reports include fibrosis stage.